| abstract |
PROBLEM TO BE SOLVED: To provide an antidote for a direct thrombin inhibitor such as dabigatran for which an improved antidote for anticoagulant therapy, particularly a specific antidote has not been disclosed so far. An antibody molecule against an anticoagulant, particularly dabigatran. The effect of the antibody as an anticoagulant antidote is also shown. [Selection figure] None |